Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Regulatory News: Celyad Oncology SA (Euronext Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric

Related Keywords

Mont Saint Guibert ,Waals Gewest ,Belgium ,New York ,United States ,Walloon Region ,Paris ,France General ,France ,Lincoln Park ,Illinois ,Brussels ,Bruxelles Capitale ,Chicago ,Belgian ,Sara Zelkovic ,Filippo Petti ,Exchange Commission ,Communications Investor Relations ,Lifesci Advisors ,Company To Lincoln Park Capital Fund ,Regulatory News ,Euronext Nasdaq ,Lincoln Park Capital Fund ,Belgian Law ,Capital Increase ,Chief Executive Officer ,Private Securities Litigation Reform Act ,Celyad Oncology ,Annual Report ,Investor Relations Director ,Sci Advisors ,Celyad ,Ncology ,Information ,Total ,Number ,Voting ,Tights ,Hares ,Article ,007 ,